Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
AIDS Vaccines | 42 | 2024 | 938 | 3.230 |
Why?
|
Simian immunodeficiency virus | 34 | 2022 | 846 | 2.640 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 17 | 2021 | 370 | 2.100 |
Why?
|
HIV-1 | 47 | 2024 | 6934 | 1.890 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 20 | 2021 | 570 | 1.860 |
Why?
|
Macaca mulatta | 60 | 2022 | 2378 | 1.600 |
Why?
|
HIV Antibodies | 26 | 2021 | 1320 | 1.450 |
Why?
|
Vaccines, DNA | 18 | 2015 | 305 | 1.450 |
Why?
|
SAIDS Vaccines | 10 | 2020 | 166 | 1.390 |
Why?
|
Immunization, Secondary | 12 | 2018 | 340 | 1.200 |
Why?
|
Antibodies, Neutralizing | 20 | 2022 | 1970 | 1.130 |
Why?
|
Viral Envelope Proteins | 4 | 2020 | 635 | 0.950 |
Why?
|
T-Lymphocytes, Cytotoxic | 17 | 2005 | 1820 | 0.870 |
Why?
|
HIV Envelope Protein gp120 | 14 | 2018 | 952 | 0.870 |
Why?
|
Viral Vaccines | 9 | 2022 | 636 | 0.830 |
Why?
|
Vaccination | 18 | 2022 | 3256 | 0.800 |
Why?
|
Antibodies, Viral | 16 | 2022 | 3164 | 0.630 |
Why?
|
HIV Infections | 26 | 2021 | 16678 | 0.590 |
Why?
|
HIV Envelope Protein gp41 | 6 | 2016 | 314 | 0.550 |
Why?
|
Poxviridae | 2 | 2007 | 37 | 0.550 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2014 | 222 | 0.550 |
Why?
|
Vaccinia virus | 6 | 2007 | 349 | 0.550 |
Why?
|
Epitopes | 13 | 2021 | 2569 | 0.520 |
Why?
|
Immunity, Cellular | 7 | 2016 | 1606 | 0.480 |
Why?
|
Epitopes, T-Lymphocyte | 8 | 2014 | 880 | 0.450 |
Why?
|
Gene Products, gag | 10 | 2012 | 337 | 0.440 |
Why?
|
Genetic Vectors | 9 | 2021 | 3420 | 0.420 |
Why?
|
Immunization | 11 | 2022 | 1255 | 0.390 |
Why?
|
CD4-Positive T-Lymphocytes | 14 | 2021 | 4379 | 0.370 |
Why?
|
Vaccines, Synthetic | 7 | 2012 | 633 | 0.370 |
Why?
|
Adenoviruses, Simian | 1 | 2009 | 14 | 0.360 |
Why?
|
T-Lymphocytes | 6 | 2016 | 10163 | 0.350 |
Why?
|
CD8-Positive T-Lymphocytes | 12 | 2019 | 4438 | 0.350 |
Why?
|
Neutralization Tests | 11 | 2020 | 758 | 0.350 |
Why?
|
Lymphocyte Activation | 8 | 2020 | 5519 | 0.340 |
Why?
|
Plasmids | 9 | 2008 | 2305 | 0.340 |
Why?
|
B-Lymphocytes | 10 | 2021 | 4664 | 0.340 |
Why?
|
Immunity, Humoral | 2 | 2012 | 596 | 0.320 |
Why?
|
Animals | 75 | 2024 | 168561 | 0.310 |
Why?
|
Immunologic Memory | 6 | 2010 | 1348 | 0.300 |
Why?
|
Adenoviruses, Human | 2 | 2009 | 257 | 0.300 |
Why?
|
HIV | 3 | 2010 | 1600 | 0.290 |
Why?
|
Antibodies, Monoclonal | 9 | 2021 | 9274 | 0.270 |
Why?
|
Immunodominant Epitopes | 3 | 2003 | 267 | 0.250 |
Why?
|
Polysaccharides | 3 | 2021 | 1051 | 0.240 |
Why?
|
Adjuvants, Immunologic | 5 | 2021 | 1000 | 0.220 |
Why?
|
RNA, Viral | 10 | 2017 | 2899 | 0.220 |
Why?
|
Immune System | 1 | 2008 | 804 | 0.220 |
Why?
|
Canarypox virus | 1 | 2002 | 10 | 0.210 |
Why?
|
CD4 Lymphocyte Count | 7 | 2009 | 2557 | 0.210 |
Why?
|
Virus Replication | 8 | 2016 | 2531 | 0.210 |
Why?
|
Molecular Mimicry | 3 | 2017 | 201 | 0.200 |
Why?
|
Gene Products, env | 5 | 2008 | 263 | 0.190 |
Why?
|
Adenoviridae | 6 | 2012 | 1096 | 0.190 |
Why?
|
Interferon-gamma | 8 | 2019 | 3199 | 0.190 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2014 | 442 | 0.190 |
Why?
|
Vagina | 3 | 2020 | 825 | 0.180 |
Why?
|
T-Lymphocytes, Helper-Inducer | 3 | 2020 | 986 | 0.180 |
Why?
|
Antigens, CD | 2 | 2000 | 4024 | 0.180 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2133 | 0.170 |
Why?
|
Lymphocyte Count | 4 | 2019 | 792 | 0.170 |
Why?
|
Viremia | 5 | 2014 | 735 | 0.170 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3769 | 0.170 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 482 | 0.170 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 514 | 0.170 |
Why?
|
Lentiviruses, Primate | 1 | 2018 | 7 | 0.170 |
Why?
|
Mice, Inbred BALB C | 10 | 2022 | 6382 | 0.160 |
Why?
|
Primates | 2 | 2021 | 543 | 0.160 |
Why?
|
Antigens, Viral | 3 | 2017 | 1034 | 0.160 |
Why?
|
Immunity, Mucosal | 3 | 2016 | 491 | 0.160 |
Why?
|
Vaccines, Subunit | 2 | 2016 | 168 | 0.160 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2016 | 87 | 0.150 |
Why?
|
Injections, Intramuscular | 5 | 2016 | 548 | 0.150 |
Why?
|
Indenes | 1 | 2018 | 57 | 0.150 |
Why?
|
Amino Acid Substitution | 4 | 2016 | 1792 | 0.150 |
Why?
|
Guanidines | 1 | 2018 | 191 | 0.150 |
Why?
|
Mucous Membrane | 2 | 2019 | 670 | 0.150 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2000 | 1368 | 0.140 |
Why?
|
Mannose | 1 | 2017 | 124 | 0.140 |
Why?
|
Antibody Formation | 4 | 2020 | 1402 | 0.140 |
Why?
|
Hydrolases | 1 | 2016 | 139 | 0.140 |
Why?
|
Cross Reactions | 2 | 2016 | 841 | 0.140 |
Why?
|
Glycopeptides | 1 | 2017 | 224 | 0.130 |
Why?
|
Pan troglodytes | 2 | 2009 | 229 | 0.130 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2015 | 130 | 0.130 |
Why?
|
Th1 Cells | 1 | 2020 | 1056 | 0.130 |
Why?
|
Consensus Sequence | 1 | 2015 | 377 | 0.120 |
Why?
|
Tryptophan | 1 | 2016 | 478 | 0.120 |
Why?
|
Surface Plasmon Resonance | 1 | 2015 | 274 | 0.120 |
Why?
|
HIV Antigens | 2 | 2017 | 347 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.120 |
Why?
|
Gene Products, pol | 3 | 2002 | 47 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2022 | 878 | 0.120 |
Why?
|
Immunoglobulin Light Chains | 1 | 2014 | 276 | 0.120 |
Why?
|
Integrases | 1 | 2016 | 533 | 0.120 |
Why?
|
Phylogeny | 3 | 2017 | 2797 | 0.120 |
Why?
|
Aspartate Aminotransferases | 1 | 2015 | 418 | 0.110 |
Why?
|
Monocytes | 2 | 2020 | 2593 | 0.110 |
Why?
|
Toll-Like Receptor 8 | 1 | 2014 | 90 | 0.110 |
Why?
|
Amino Acid Sequence | 10 | 2017 | 13814 | 0.110 |
Why?
|
Nanoparticles | 2 | 2022 | 1902 | 0.110 |
Why?
|
Mutation | 7 | 2021 | 29717 | 0.110 |
Why?
|
HEK293 Cells | 3 | 2020 | 4200 | 0.110 |
Why?
|
Immunoglobulin A | 1 | 2016 | 992 | 0.110 |
Why?
|
Toll-Like Receptor 7 | 1 | 2014 | 172 | 0.110 |
Why?
|
Toll-Like Receptor 9 | 1 | 2014 | 212 | 0.110 |
Why?
|
Vaccines | 2 | 2021 | 817 | 0.110 |
Why?
|
Measles Vaccine | 1 | 2012 | 76 | 0.100 |
Why?
|
Interleukin-2 | 4 | 2005 | 1887 | 0.100 |
Why?
|
Immunoglobulin G | 3 | 2016 | 4554 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.100 |
Why?
|
Disease Models, Animal | 7 | 2017 | 18006 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2020 | 1575 | 0.090 |
Why?
|
Rectum | 1 | 2015 | 903 | 0.090 |
Why?
|
Peptides | 4 | 2016 | 4392 | 0.090 |
Why?
|
Protein Conformation | 2 | 2015 | 4013 | 0.090 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 153 | 0.090 |
Why?
|
Intestinal Mucosa | 2 | 2015 | 3038 | 0.080 |
Why?
|
Immunization, Passive | 2 | 2021 | 625 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2009 | 221 | 0.080 |
Why?
|
Humans | 40 | 2024 | 742088 | 0.080 |
Why?
|
Malaria Vaccines | 1 | 2009 | 158 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2012 | 1526 | 0.080 |
Why?
|
Mice | 16 | 2022 | 81045 | 0.080 |
Why?
|
Antibodies, Blocking | 2 | 2020 | 254 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2005 | 1366 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2556 | 0.070 |
Why?
|
Molecular Sequence Data | 7 | 2015 | 18112 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1372 | 0.070 |
Why?
|
Mycobacterium smegmatis | 1 | 2006 | 119 | 0.070 |
Why?
|
Adenovirus E1 Proteins | 1 | 2005 | 6 | 0.070 |
Why?
|
Viral Load | 6 | 2008 | 3292 | 0.070 |
Why?
|
Adenovirus E3 Proteins | 1 | 2005 | 7 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7721 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2020 | 13029 | 0.070 |
Why?
|
Macaca | 2 | 2024 | 440 | 0.060 |
Why?
|
Cytokines | 4 | 2010 | 7317 | 0.060 |
Why?
|
Glycosylation | 2 | 2021 | 1123 | 0.060 |
Why?
|
Regression Analysis | 2 | 2017 | 6452 | 0.060 |
Why?
|
Cell Lineage | 3 | 2017 | 2504 | 0.060 |
Why?
|
Restriction Mapping | 1 | 2004 | 878 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2002 | 2231 | 0.060 |
Why?
|
Colony-Stimulating Factors | 1 | 2003 | 216 | 0.060 |
Why?
|
Antibody Affinity | 2 | 2014 | 253 | 0.060 |
Why?
|
Antibody Specificity | 2 | 2017 | 1094 | 0.050 |
Why?
|
Protein Multimerization | 2 | 2017 | 971 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 902 | 0.050 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2002 | 329 | 0.050 |
Why?
|
Malaria, Falciparum | 1 | 2009 | 1071 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 370 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2016 | 4250 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2004 | 969 | 0.050 |
Why?
|
Receptors, OX40 | 1 | 2020 | 43 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2004 | 3862 | 0.050 |
Why?
|
Binding Sites | 2 | 2020 | 6115 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 304 | 0.040 |
Why?
|
Dimerization | 1 | 2021 | 893 | 0.040 |
Why?
|
Chemokines | 1 | 2003 | 954 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2020 | 315 | 0.040 |
Why?
|
Protein Binding | 3 | 2017 | 9387 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 6171 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 547 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2024 | 1599 | 0.040 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 349 | 0.040 |
Why?
|
Kinetics | 2 | 2006 | 6474 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2019 | 497 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2017 | 169 | 0.040 |
Why?
|
Gene Deletion | 1 | 2005 | 2751 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2017 | 117 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 418 | 0.030 |
Why?
|
Antigenic Variation | 1 | 2016 | 125 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9735 | 0.030 |
Why?
|
Gene Expression | 2 | 2021 | 7790 | 0.030 |
Why?
|
Female | 15 | 2020 | 379592 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2014 | 19223 | 0.030 |
Why?
|
Lymphocyte Depletion | 3 | 2004 | 608 | 0.030 |
Why?
|
Haplorhini | 1 | 2016 | 551 | 0.030 |
Why?
|
Colon | 2 | 2019 | 1773 | 0.030 |
Why?
|
DNA, Viral | 1 | 2002 | 2224 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1998 | 880 | 0.030 |
Why?
|
RNA Stability | 1 | 2017 | 322 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2020 | 2723 | 0.030 |
Why?
|
DNA Primers | 3 | 2005 | 2892 | 0.030 |
Why?
|
Complement System Proteins | 1 | 2017 | 795 | 0.030 |
Why?
|
Feces | 1 | 2020 | 1394 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2014 | 311 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2016 | 14554 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1692 | 0.030 |
Why?
|
Immune Evasion | 1 | 2016 | 360 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 1866 | 0.030 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2011 | 26 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3770 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2016 | 1866 | 0.030 |
Why?
|
Cross-Priming | 1 | 2011 | 82 | 0.030 |
Why?
|
Phagocytosis | 1 | 2017 | 1538 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4886 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1202 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1538 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1749 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 341 | 0.020 |
Why?
|
Protein Engineering | 1 | 2014 | 541 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2011 | 437 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4211 | 0.020 |
Why?
|
Measles | 1 | 2012 | 168 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1835 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2011 | 1386 | 0.020 |
Why?
|
Disease Progression | 5 | 2006 | 13256 | 0.020 |
Why?
|
Glycoproteins | 1 | 2017 | 2260 | 0.020 |
Why?
|
Transgenes | 1 | 2012 | 1009 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2257 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 21821 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2039 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 2009 | 253 | 0.020 |
Why?
|
Liposomes | 1 | 2011 | 758 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1477 | 0.020 |
Why?
|
Male | 7 | 2020 | 349538 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6608 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5454 | 0.020 |
Why?
|
Ligands | 1 | 2014 | 3293 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4147 | 0.020 |
Why?
|
Time Factors | 4 | 2017 | 40054 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2008 | 4414 | 0.020 |
Why?
|
Granzymes | 1 | 2006 | 270 | 0.020 |
Why?
|
Chemokine CCL4 | 1 | 2004 | 128 | 0.020 |
Why?
|
Hepatitis A virus | 1 | 2004 | 14 | 0.020 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2004 | 122 | 0.020 |
Why?
|
Cell Count | 1 | 2008 | 1831 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2016 | 5095 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9410 | 0.010 |
Why?
|
Tetanus Toxoid | 1 | 2004 | 193 | 0.010 |
Why?
|
Genes, gag | 1 | 2002 | 61 | 0.010 |
Why?
|
Antigens, CD20 | 1 | 2003 | 198 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2004 | 675 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2006 | 1073 | 0.010 |
Why?
|
Jejunum | 1 | 2002 | 480 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12797 | 0.010 |
Why?
|
Virulence | 1 | 2004 | 1328 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 2009 | 1726 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1619 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7901 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 2000 | 573 | 0.010 |
Why?
|
Viral Proteins | 1 | 2005 | 1899 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1998 | 964 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2005 | 1837 | 0.010 |
Why?
|
Solubility | 1 | 1998 | 1083 | 0.010 |
Why?
|
Immunity | 1 | 2002 | 1011 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2003 | 1937 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56350 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 62966 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4187 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85649 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11363 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 5979 | 0.010 |
Why?
|
Cell Movement | 1 | 2002 | 5212 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 12071 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 213127 | 0.000 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4933 | 0.000 |
Why?
|
Adult | 1 | 2020 | 213712 | 0.000 |
Why?
|
Cohort Studies | 1 | 2008 | 40450 | 0.000 |
Why?
|
Concepts
(262)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_